Is Igalmi in shortage in 2026? Get the latest update on Igalmi availability, why it's hard to find, current pricing, and how to locate it.
If you've been told you need Igalmi (Dexmedetomidine sublingual film) and your facility can't find it, you may be wondering: is Igalmi in shortage? What's going on with availability, and what are your options?
In this 2026 update, we'll cover the current state of Igalmi supply, explain why it's difficult to find, discuss costs, and share practical steps for locating it.
As of early 2026, Igalmi is not listed on the FDA's official drug shortage database. That's the good news. There is no formal manufacturing shortage affecting Igalmi's supply.
However, the reality on the ground is more nuanced. Many healthcare facilities — especially smaller hospitals, community psychiatric centers, and rural emergency departments — report difficulty obtaining Igalmi. This isn't a traditional "shortage" in the FDA sense, but rather an availability and distribution challenge rooted in Igalmi's unique characteristics as a specialty product.
Several factors contribute to Igalmi's limited availability in 2026:
Igalmi is primarily distributed to hospitals, psychiatric inpatient facilities, and emergency departments — not retail pharmacies. If your facility hasn't added Igalmi to its formulary, it may not have a supply channel established.
BioXcel Therapeutics is the sole manufacturer of Igalmi. With no competing manufacturers and no generic version, supply depends entirely on one company's production and distribution capacity.
Igalmi is approved specifically for acute agitation in schizophrenia and bipolar disorder. This relatively narrow market means distributors may not stock it as aggressively as higher-volume medications.
Many hospital pharmacy and therapeutics (P&T) committees haven't added Igalmi to their formularies, either due to cost concerns or because they have established protocols using other medications for acute agitation.
For a deeper look at these factors, see our article on why Igalmi is so hard to find.
Cost is a significant factor in Igalmi's availability challenges. Here's what you need to know about pricing:
For detailed savings strategies, check out our guide on how to save money on Igalmi.
While there's no generic Igalmi on the immediate horizon, the landscape for treating acute agitation continues to evolve:
Learn more about alternatives in our article on alternatives to Igalmi.
If you need Igalmi, here are the most effective steps to locate it:
For more tips, read our full guide on how to find Igalmi in stock near you.
While Igalmi isn't in a formal FDA-listed shortage in 2026, its limited distribution network, single manufacturer, and specialty nature create real-world availability challenges for patients and providers. The key is to use the right tools — like Medfinder — and work closely with your healthcare team to ensure access to the treatment you need.
If Igalmi truly isn't available, don't delay treatment. Talk to your provider about effective alternatives that may be more readily accessible at your facility.
More Igalmi resources:
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
